Table 3.
Thr 1 | Cen 1 | Cha1 | SDCO1 | SDCP1 | DDCO1 | DDCP1 | CDC1 | NDCO1 | NDCP1 | Fct 1 | Sym 1 | Hlt 1 | Thr 2 | Cen 2 | Cha2 | SDCO2 | SDCP2 | DDCO2 | DDCP2 | CDC 2 | NDCO 2 | NDCP 2 | Fct 2 | Sym 2 | Hlt 2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thr1 | 1 | |||||||||||||||||||||||||
Cen1 | 0.76** | 1 | ||||||||||||||||||||||||
Cha1 | −0.03 | 0.18* | 1 | |||||||||||||||||||||||
SDCO1 | −0.33** | −0.21* | 0.28** | 1 | ||||||||||||||||||||||
SDCP1 | −0.35** | −0.28** | 0.15 | 0.67** | 1 | |||||||||||||||||||||
DDCO1 | −0.23** | −0.26** | 0.12 | 0.59** | 0.41** | 1 | ||||||||||||||||||||
DDCP1 | −0.20* | −0.14 | 0.15 | 0.58** | 0.77** | 0.36** | 1 | |||||||||||||||||||
CDC1 | −0.36** | −0.25** | 0.27** | 0.73** | 0.73** | 0.47** | 0.65** | 1 | ||||||||||||||||||
NDCO1 | −0.07 | 0.06 | 0.24** | 0.19* | 0.15 | 0.12 | 0.15 | 0.24** | 1 | |||||||||||||||||
NDCP1 | −0.15 | 0.06 | 0.32** | 0.26** | 0.37** | 0.10 | 0.32** | 0.32** | 0.65** | 1 | ||||||||||||||||
Fct1 | 0.43** | 0.46** | −0.11 | −0.11 | −0.13 | −0.08 | 0.01 | −0.15 | −0.07 | −0.10 | 1 | |||||||||||||||
Sym1 | 0.35** | 0.34** | 0.03 | −0.13 | −0.16 | −0.09 | −0.01 | −0.18* | 0.05 | −0.03 | 0.79** | 1 | ||||||||||||||
Hlt1 | −0.44** | −0.38** | 0.09 | 0.16 | 0.17* | 0.18* | 0.11 | 0.20* | 0.01 | 0.07 | −0.57** | −0.50** | 1 | |||||||||||||
Thr2 | 0.56** | 0.51** | −0.04 | .-0.23** | −0.17* | −0.17* | −0.03 | −0.16 | 0.06 | 0.00 | 0.39** | 0.35** | −0.35** | 1 | ||||||||||||
Cen2 | 0.41** | 0.52** | 0.07 | −0.08 | −0.08 | −0.16 | 0.01 | −0.05 | 0.15 | 0.15 | 0.35** | 0.24** | −0.33** | 0.75** | 1 | |||||||||||
Cha2 | −0.02 | 0.11 | 0.45** | 0.13 | 0.17* | −0.04 | 0.16 | 0.28** | 0.12 | 0.23** | −0.07 | 0.00 | 0.007 | 0.14 | 0.22** | 1 | ||||||||||
SDCO2 | −0.26** | −0.13 | 0.21** | 0.61** | 0.66** | 0.40** | 0.56** | 0.63** | 0.25** | 0.36** | −0.10 | −0.15 | 0.17* | −0.09 | −0.02 | 0.18* | 1 | |||||||||
SDCP2 | −0.43** | −0.28** | 0.33** | 0.68** | 0.71** | 0.43** | 0.57** | 0.77** | 0.26** | 0.33** | −0.19* | −0.16* | 0.27** | −0.33** | −0.17* | 0.24** | 0.67** | 1 | ||||||||
DDCO2 | −0.25** | −0.17* | 0.04 | 0.39** | 0.49** | 0.30** | 0.49** | 0.43** | 0.17* | 0.25** | −0.04 | −0.05 | 0.12 | −0.05 | −0.01 | 0.18* | 0.68** | 0.48** | 1 | |||||||
DDCP2 | −0.33** | −0.24** | 0.26** | 0.43** | 0.44** | 0.40** | 0.50** | 0.54** | 0.06 | 0.15 | −0.14 | −0.07 | 0.28** | −0.32** | −0.21* | 0.16* | 0.34** | 0.64** | 0.23** | 1 | ||||||
CDC2 | −0.37** | −0.26** | 0.24** | 0.64** | 0.72** | 0.40** | 0.58** | 0.84** | 0.25** | 0.31** | −0.23** | −0.22** | 0.30** | −0.22** | −0.12 | 0.26** | 0.72** | 0.82** | 0.53** | 0.56** | 1 | |||||
NDCO2 | −0.08 | 0.07 | 0.11 | 0.24** | 0.36** | 0.14 | 0.33** | 0.34** | 0.62** | 0.64** | 0.04 | −0.01 | −0.05 | 0.03 | 0.22** | 0.17* | 0.34** | 0.29** | 0.28** | 0.07 | 0.24** | 1 | ||||
NDCP2 | −0.14 | 0.07 | 0.23** | 0.29** | 0.28** | 0.13 | 0.17* | 0.33** | 0.56** | 0.62** | −0.04 | −0.007 | 0.03 | −0.002 | 0.14 | 0.21* | 0.35** | 0.37** | 0.26** | 0.07 | 0.28** | 0.68** | 1 | |||
Fct2 | 0.16 | 0.09 | −0.09 | −0.10 | −0.07 | −0.03 | −0.01 | −0.01 | −0.15 | −0.18* | 0.33** | 0.38** | −0.16 | 0.39** | 0.21* | 0.16 | −0.11 | −0.16* | −0.06 | −0.05 | −0.10 | −0.19* | −0.12 | 1 | ||
Sym2 | 0.07 | 0.10 | 0.05 | −0.13 | −0.09 | −0.04 | −0.05 | −0.02 | −0.04 | −0.07 | 0.24** | 0.44** | −0.12 | 0.24** | 0.16* | 0.22** | −0.19* | −0.10 | −0.09 | −0.08 | −0.10 | −0.10 | −0.03 | 0.76** | 1 | |
Hlt2 | −0.21** | −0.11 | 0.09 | 0.16 | 0.08 | 0.03 | 0.10 | 0.14 | 0.10 | 0.12 | −0.34** | −0.37** | 0.49** | −0.29** | −0.23** | −0.09 | 0.20* | 0.19* | 0.20* | 0.03 | 0.24** | 0.05 | 0.001 | −0.55** | −0.48** | 1 |
*p < 0.05, **p < 0.01, ***p < 0.001. Thr, Cen, Cha, scores correspond to the Threat, Centrality, Challenge subscales of the Stress Appraisal Measure questionnaire; SDCO, SDCP, DDCO, DDCP, CDC, NDCO, NDCP, subscales Supportive dyadic coping by oneself, Supportive dyadic coping by partner, Delegated dyadic coping by oneself, Delegated dyadic coping by partner, Common dyadic coping, Negative dyadic coping by oneself, Negative dyadic coping by partner. Fct, Sy, Hlt, subscales Functionality, Symptoms and Global health/QoL of the European Organisation for Research and Treatment of Cancer questionnaire QLQ C30. Variables corresponding to patients are marked 1. Variables corresponding to partners are marked 2.